WallStreetZenWallStreetZen

NASDAQ: ZNTL
Zentalis Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ZNTL past revenue growth

How has ZNTL's revenue growth performed historically?
Company
N/A
Industry
144.63%
Market
17.55%
ZNTL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ZNTL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

ZNTL earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$292.2M
Current Profit Margin
0%

ZNTL Return on Equity

Current Company
-63.9%
Current Industry
-63.5%
Current Market
188%
ZNTL's Return on Equity (-63.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ZNTL announces earnings.

ZNTL Return on Assets

Current Company
-52%
Current Industry
2.9%
ZNTL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ZNTL Return on Capital Employed

Current Company
-60.7%
Current Industry
19.5%
ZNTL's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ZNTL vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ZNTL$0.00-$291.40M-$292.19M-100.00%N/A
TNGX$36.53M-$95.59M-$101.74M+10.33%N/A
PRTC$3.33M-$30.24M-$65.70M-30.64%N/A
ETNB$0.00-$133.26M-$142.19MN/AN/A
SPRY$30.00k-$54.29M-$54.37M-92.62%N/A
View Top Biotech Stocks

ZNTL earnings dates

Next earnings date
Jun 14, 2024

Zentalis Pharmaceuticals Earnings & Revenue FAQ

What were ZNTL's earnings last quarter?

On Invalid Date, Zentalis Pharmaceuticals (NASDAQ: ZNTL) reported Q4 2023 earnings per share (EPS) of -$0.83, up 9.78% year over year. Total Zentalis Pharmaceuticals earnings for the quarter were -$60.92 million. In the same quarter last year, Zentalis Pharmaceuticals's earnings per share (EPS) was -$0.92.

If you're new to stock investing, here's how to buy Zentalis Pharmaceuticals stock.

What was ZNTL's earnings growth in the past year?

As of Q2 2024, Zentalis Pharmaceuticals's earnings has grown year over year. Zentalis Pharmaceuticals's earnings in the past year totalled -$292.19 million.

What is ZNTL's earnings date?

Zentalis Pharmaceuticals's earnings date is Invalid Date. Add ZNTL to your watchlist to be reminded of ZNTL's next earnings announcement.

What was ZNTL's revenue last quarter?

On Invalid Date, Zentalis Pharmaceuticals (NASDAQ: ZNTL) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Zentalis Pharmaceuticals's revenue was $0.00.

What was ZNTL's revenue growth in the past year?

As of Q2 2024, Zentalis Pharmaceuticals's revenue has grown null year over year. Zentalis Pharmaceuticals's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.